✦ LIBER ✦

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

✍ Scribed by Michela Donadio; Mara Ardine; Alfredo Berruti; Giuliana Ritorto; Elena Fea; Marinella Mistrangelo; Zaira Coccorullo; Paola Bergnolo; Alessandro Comandone; Oscar Bertetto

Publisher: Springer
Year: 2003
Tongue: English
Weight: 179 KB
Volume: 52
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-003-0632-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine as prolonged infusion and vi

Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study

✍ Peter Schmid; Volker Heilmann; Carsten-Oliver Schulz; Annette Dieing; Silvia Leh 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 205 KB

A phase II study of biweekly pemetrexed

A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer

✍ Susan F. Dent; Stan Gertler; Shailendra Verma; Roanne Segal; Vince Young; Rakesh 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 215 KB

Phase II study of oral vinorelbine in co

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes

✍ Alison Jones; Mary O’Brien; Harald Sommer; Elzbieta Nowara; Anja Welt; Tadeusz P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 364 KB

Biweekly vinorelbine and gemcitabine as

Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer

✍ N. Xenidis; K. Neanidis; K. Amarantidis; P. Dimopoulos; E. Chamalidou; D. Pitsia 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 243 KB

A phase I/II study of vinorelbine, doxor

A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer

✍ Smitha Subramanyan; Martin D. Abeloff; Stephen E. Bond; Nancy E. Davidson; John 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 86 KB

A phase II trial of docetaxel (Taxotere®

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB